Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted): 2011-2025
Historic EPS (Weighted Average and Diluted) for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to -$0.02.
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) rose 90.48% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.25, marking a year-over-year decrease of 150.00%. This contributed to the annual value of -$0.02 for FY2024, which is 96.67% up from last year.
- According to the latest figures from Q3 2025, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.02, which was up 81.82% from -$0.11 recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.41 in Q1 2024 and a low of -$0.40 during Q4 2022.
- Over the past 3 years, Fennec Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.10 (recorded in 2023), while the average stood at -$0.08.
- Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) showed a top increase of 278.26% in 2024 and a maximum decrease of 200.00% in 2024.
- Quarterly analysis of 5 years shows Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.16 in 2021, then plummeted by 93.75% to -$0.40 in 2022, then surged by 75.00% to -$0.10 in 2023, then rose by 20.00% to -$0.08 in 2024, then surged by 90.48% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.02 for Q3 2025, versus -$0.11 for Q2 2025 and -$0.04 for Q1 2025.